Commentary

Correlation of the Clinical Response to ACTH Treatment with the Endocrine Status in Myasthenia Gravis

Authors: CHARLES A. CAPE MD, NORBERTO J. ARBONA MD

Abstract

The clinical response to ACTH treatment is correlated with the endocrine status in 21 myasthenia gravis patients. Myasthenics with normal endocrine function will almost always improve; whereas, patients with abnormal endocrine function do not correlate as well with ACTH treatment failures. Reasons are given why these results should be considered preliminary

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References